Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Thymic Function Predicts Response to Mesenchymal Stromal Cell Treatment in Chronic GvHD: A Phase II Clinical Study

Erik Boberg, Lena Von Bahr, MD PhD, Nina Heldring, PhD, Gabriel Afram, MD, Ellen Iacobaeus, MD PhD, Carina Lindström, RN, Karin Garming-Legert, DMD, PhD, Per Ljungman, Rachael Sugars, PhD, Lindsay Davies, MD PhD, Nadir Kadri, PhD, Katarina Le Blanc, MD PhD

Blood (2017) 130 (Supplement 1): 3253.

https://doi.org/10.1182/blood.V130.Suppl_1.3253.3253

Published: 2017

Journal Articles

Progression in Patients with with Low- and Intermediate-1 Risk Del(5q) MDS Is Predicted By a Limited Subset of Mutations

Christian Scharenberg, MD, Petter S. Woll, PhD, Valentina Giai, MD PhD, Andrea Pellagatti, PhD, Leonie Saft, MD PhD, Marios Dimitriou, Martin Jädersten, Monika Jansson, Iyadh Douagi, PhD, Donna S. Neuberg, ScD, Mohsen Karimi, Katarina Le Blanc, MD, PhD, Jacqueline Boultwood, PhD, Sten Eirik Jacobsen, MD PhD, Eva Hellstrom-Lindberg, MD PhD

Blood (2016) 128 (22): 4329.

https://doi.org/10.1182/blood.V128.22.4329.4329

Published: 2016

Journal Articles

Manufacturing of Mesenchymal Stromal Cells for the Treatment of Graft-Versus-Host Disease: A Survey within the European Society of Blood and Marrow Transplantation

Blood (2016) 128 (22): 3374.

https://doi.org/10.1182/blood.V128.22.3374.3374

Published: 2016

Journal Articles

Phenotypic and Functional Alterations of Bone Marrow Mesenchymal Stem and Progenitor Cells in Chronic Myeloid Leukemia

Monika Dolinska, Johannis Klang, Pingnan Xiao, MD, Andranik Durgaryan, Lakshmi Sandhow, Anne-Sofie Johansson, Makoto Kondo, Stefan Deneberg, MD, PhD, Johanna Ungerstedt, Associate Professor, Katarina Le Blanc, MD, PhD, Leif Stenke, MD PhD, Marja Ekblom, Ulla Stromberg, MDPhD, Satu Mustjoki, MD PhD, Soren Lehmann, MD PhD, Hong Qian, PhD

Blood (2015) 126 (23): 2398.

https://doi.org/10.1182/blood.V126.23.2398.2398

Published: 2015

Journal Articles

Treatment of Chronic GvHD with Mesenchymal Stromal Cells Induces Durable Responses; A Phase II Study

Lena Von Bahr, MD, Lindsay Davies, PhD, Gabriel Afram, MD, Carina Modin, Karin Garming-Legert, PhD, Hans Hägglund, MD PhD, Per T. Ljungman, MD PhD, Katarina Le Blanc, MD, PhD

Blood (2015) 126 (23): 3138.

https://doi.org/10.1182/blood.V126.23.3138.3138

Published: 2015

Journal Articles

Early Intervention with Mesenchymal Stromal Cells for Refractory Grade III-IV Graft Versus Host Disease In Children Results In Excellent Long Term Outcome

Lynne Margaret Ball, MD, PhD, Maria E. Bernardo, MD, PhD, Jaap Jan Zwaginga, MD, PhD, Maarten van Tol, PhD, Angela Cometa, Helene Roelofs, PhD, Giovanna Giorgiani, Cornelia M Jol-van der Zijde, PhD, Maria Antonietta Avanzini, MD, Katarina Le Blanc, MD, PhD, Alice Bertaina, Francesco Frassoni, MD, Willem E. Fibbe, MD, PhD, Olle Ringden, MD, R. Maarten Egeler, MD, PhD, Franco Locatelli, MD, Arjan Lankester, MD, PhD

Blood (2010) 116 (21): 2336.

https://doi.org/10.1182/blood.V116.21.2336.2336

Published: 2010

Journal Articles

Human Embryonic Stem Cell-Derived Mesenchymal Stroma Cells (hES-MSC) Share Basic Properties with Bone Marrow MSC, They Have Potent Stroma Support Capacities but Lack Immune-Modulatory Function. Implications for off-the Shelf ES-MSC Therapies.

Ou Li, PhD, Ariane Tormin, PhD, Jan Claas Brune, MS, Berit Sundberg, Johan Hyllner, PhD, Katarina Le Blanc, MD, PhD, Stefan Scheding, MD

Blood (2010) 116 (21): 3858.

https://doi.org/10.1182/blood.V116.21.3858.3858

Published: 2010

Journal Articles

Human Mesenchymal Stem Cells Elicit Complement Activation in Human Blood.

Katarina Le Blanc, MD, PhD, Guido Moll, Ida Rasmusson, Kristina Nilsson Ekdahl, Graciela Elgue, Berit Sundberg, Bo Nilsson

Blood (2009) 114 (22): 4580.

https://doi.org/10.1182/blood.V114.22.4580.4580

Published: 2009

Journal Articles

Prospecitve Quantitative PCR Monitoring of Allogeneic Stem Cell Transplant (SCT) Patients at High Risk for EBV Associated PTLD.

Hamdy Omar, MD, Hans Hägglund, MD, PhD, Åsa Gustafsson-Jernberg, MD, PhD, Katarina Le Blanc, MD, PhD, Jonas Mattsson, MD, PhD, Mats Remberger, PhD, Olle Ringdén, MD, PhD, Elda Sparrelid, MD, PhD, Mikael Sundin, Jacek H. Winiarski, MD, PhD, Zhibing Yun, PhD, Per T. Ljungman, MD, PhD

Blood (2007) 110 (11): 2969.

https://doi.org/10.1182/blood.V110.11.2969.2969

Published: 2007

Journal Articles

Mesenchymal Stem Cells for Treatment of Severe Acute Graft-Versus-Host Disease.

Katarina Le Blanc, MD, PhD, Francesco Frassoni, MD, PhD, Lynne Ball, MD, PhD, Edoardo Lanino, MD, PhD, Berit Sundberg, B.Sc, Lena Lonnies, B.Sc, Helene Roelofs, PhD, Giorgio Dini, MD, PhD, Andrea Bacigalupo, MD, PhD, Franco Locatelli, MD, PhD, Willem F. Fibbe, MD, PhD, Olle Ringden, MD, PhD

Blood (2006) 108 (11): 5304.

https://doi.org/10.1182/blood.V108.11.5304.5304

Published: 2006

Journal Articles

Mesenchymal Stem Cells for Treatment of Severe Acute Graft-Versus-Host Disease.

Katarina Le Blanc, MD, PhD, Francesco Frassoni, MD,PhD, Lynne Ball, MD, PhD, Edoardo Lanino, MD, PhD, Berit Sundberg, B.Sc, Helena Lonnies, B.Sc, Helene Roelofs, PhD, Giorgio Dini, MD, PhD, Andrea Bacigalupo, MD, PhD, Franco Locatelli, MD, PhD, Willem F. Fibbe, MD, PhD, Olle Ringden, MD, PhD

Blood (2006) 108 (11): 2918.

https://doi.org/10.1182/blood.V108.11.2918.2918

Published: 2006

Journal Articles

Transplantation of Haplo-Identical Bone Marrow-Derived Mesenchymal Stem Cells Together with Hematopoietic Stem Cells To Promote Engraftment in Children. A Phase I/II Multicenter Study.

Lynne Margaret van Velzen-Ball, MD, PhD, Katarina Le Blanc, MD, PhD, Arjen C. Lankester, MD, PhD, Helene Roelofs, PhD, Maarten Egeler, MD, PhD, Francesco Frassoni, MD, PhD, Olle Ringdén, MD, PhD, Willem E. Fibbe, MD, PhD

Blood (2005) 106 (11): 2911.

https://doi.org/10.1182/blood.V106.11.2911.2911

Published: 2005

Journal Articles

Mesenchymal Stem Cells for Treatment of Severe Acute and Extensive Chronic Graft-Versus-Host Disease.

Katarina Le Blanc, MD, PhD, Francesco Frassoni, MD, Lynne Ball, MD, Mehmet Uzunel, PhD, Edoardo Lanini, MD, Berit Sundberg, Helena Lonnies, Giorgio Dini, MD, Andrea Bacigalupo, MD, Franco Locatelli, MD, Willem E. Fibbe, MD, Olle T.H. Ringden, MD, PhD

Blood (2005) 106 (11): 143.

https://doi.org/10.1182/blood.V106.11.143.143

Published: 2005

Journal Articles

Mesenchymal Stem Cell Engraftment in Bone Following In Utero Transplantation in a Patient with Severe Osteogenesis Imperfecta.

Katarina Le Blanc, MD, PhD, Cecilia Götherström, MSc, Olle Ringdén, MD, PhD, Moustapha Hassan, MD, PhD, Robert McMahon, PhD, Edwin Horwitz, MD, PhD, Göran Anneren, MD, PhD, Ove Axelsson, MD, PhD, Janice Nunn, PhD, Uwe Ewald, MD, PhD, Solveig Nordén-Lindeberg, MD, PhD, Monika Jansson, BSc, Ann Dalton, PhD, Eva Åström, MD, Magnus Westgren, MD, PhD

Blood (2004) 104 (11): 505.

https://doi.org/10.1182/blood.V104.11.505.505

Published: 2004

NARROW

Thymic Function Predicts Response to Mesenchymal Stromal Cell Treatment in Chronic GvHD: A Phase II Clinical Study

Progression in Patients with with Low- and Intermediate-1 Risk Del(5q) MDS Is Predicted By a Limited Subset of Mutations

Manufacturing of Mesenchymal Stromal Cells for the Treatment of Graft-Versus-Host Disease: A Survey within the European Society of Blood and Marrow Transplantation

Phenotypic and Functional Alterations of Bone Marrow Mesenchymal Stem and Progenitor Cells in Chronic Myeloid Leukemia

Treatment of Chronic GvHD with Mesenchymal Stromal Cells Induces Durable Responses; A Phase II Study

Early Intervention with Mesenchymal Stromal Cells for Refractory Grade III-IV Graft Versus Host Disease In Children Results In Excellent Long Term Outcome

Human Embryonic Stem Cell-Derived Mesenchymal Stroma Cells (hES-MSC) Share Basic Properties with Bone Marrow MSC, They Have Potent Stroma Support Capacities but Lack Immune-Modulatory Function. Implications for off-the Shelf ES-MSC Therapies.

Human Mesenchymal Stem Cells Elicit Complement Activation in Human Blood.

Prospecitve Quantitative PCR Monitoring of Allogeneic Stem Cell Transplant (SCT) Patients at High Risk for EBV Associated PTLD.

Mesenchymal Stem Cells for Treatment of Severe Acute Graft-Versus-Host Disease.

Mesenchymal Stem Cells for Treatment of Severe Acute Graft-Versus-Host Disease.

Transplantation of Haplo-Identical Bone Marrow-Derived Mesenchymal Stem Cells Together with Hematopoietic Stem Cells To Promote Engraftment in Children. A Phase I/II Multicenter Study.

Mesenchymal Stem Cells for Treatment of Severe Acute and Extensive Chronic Graft-Versus-Host Disease.

Mesenchymal Stem Cell Engraftment in Bone Following In Utero Transplantation in a Patient with Severe Osteogenesis Imperfecta.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only